Travere Therapeutics (TVTX) Stock: Buy, Sell, or Hold?
TVTX - Travere Therapeutics, Inc. Common Stock
$52.43
-0.15 (-0.29%)
▼
5d:
-0.68%
30d:
-12.37%
90d:
-8.59%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Oct 29, 2026
5d
Get Alerted When TVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TVTX trading at deep discount. Market pricing in -7.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: TVTX trading at deep discount. Market pricing in -7.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$128.79
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$79.97
34.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TVTX is currently trading at $52.43, which is considered slightly low relative to its 30-day fair value range of $52.32 to $61.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.2) compared to its historical average (11.6). Remarkably, the market is currently pricing in an annual earnings decline of 7.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $49.46, while resistance sits at $55.57.
Market Sentiment: TVTX scores 95/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $75.21 (+43.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $49.46, while resistance sits at $55.57.
Market Sentiment: TVTX scores 95/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $75.21 (+43.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$52.32 -
$61.82
Company Quality Score
75/100
(STRONG BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (95/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.5% below Wall St target ($75.21)
- BULLISH: Bottoming setup score 95/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$52.32 -
$61.82
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$49.46
Resistance Level
$55.57
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.20
Wall Street Target
$75.21
(+43.5%)
Revenue Growth (YoY)
48.2%
Profit Margin
-7.3%
Valuation Discount vs History
-7.6% cheaper
PE vs Historical
9.2 vs 11.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.6%
(market-implied from PE analysis)
1-Year Target
$48.45
(-8%)
2-Year Target
$44.76
(-15%)
3-Year Target
$41.36
(-21%)
3-Yr Target (if PE normalizes)
(PE: 9→12)
$52.17
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 242.1%)
$382.14
(+629%)
Base:
(SPY PE: 9.2, Growth: 242.1%)
$176.95
(+238%)
Bear:
(PE: 7.8, Growth: 242.1%)
$150.41
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.2 to 11.6
Stabilization Target:
$66.13
(+26.1%)
PE Expansion Potential:
+26.1%
Share & Embed Analysis
Last updated: October 22, 2026 11:05 PM ET
Data refreshes hourly during market hours. Next update: 12:05 AM
Data refreshes hourly during market hours. Next update: 12:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 50 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 39 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 70 BUY |
|
PVLA
Palvella Therapeutics, I… |
STRONG BUY
15 analysts |
$231 | 68 BUY |
Advanced TVTX Option Strategies
Professional options setups generated by AI based on today's TVTX price and gamma walls.
